How bacteria that cause inflammatory colitis outmaneuver our body's defenses

Bacteria use multiple defense mechanisms to survive in the host body. Shigella bacteria that cause colitis disable multiple ...
WebMD

Omvoh for Ulcerative Colitis

Omvoh is a biologic medicine used to treat moderate to severe ulcerative colitis. Ulcerative colitis is an inflammatory bowel disease that causes inflammation in parts of the digestive tract. Common ...
EurekAlert!

No evidence that medications trigger microscopic colitis in older adults

Study from Mass General Brigham and Karolinska Institutet researchers suggests that patients with the condition do not need to stop taking important medications Microscopic colitis (MC) is a chronic ...
Medindia

Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved a single-injection, once-mo ...
Nasdaq

TREMFYA® (guselkumab) receives U.S. FDA approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson's leadership in inflammatory ...

The first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis, TREMFYA® showed highly statistically significant rates of endoscopic remission at one year in the pivotal ...